A pilot study on the efficacy of a seaweed mud application in the treatment of cellulite.

cellulite cosmeceutical non-invasive therapy seaweed mud

Journal

Journal of cosmetic dermatology
ISSN: 1473-2165
Titre abrégé: J Cosmet Dermatol
Pays: England
ID NLM: 101130964

Informations de publication

Date de publication:
07 Mar 2024
Historique:
revised: 05 02 2024
received: 13 10 2023
accepted: 23 02 2024
medline: 7 3 2024
pubmed: 7 3 2024
entrez: 7 3 2024
Statut: aheadofprint

Résumé

Cellulite represents a common multi-factorial condition that affects nearly all women and is now recognized as a clinical condition associated with systemic factors and negative psychological effects. Several noninvasive and minimally invasive treatments were developed during the last few years, but limited evidence supports many of them due to lack of evidence, insufficient participants, and potential adverse effects. This study aimed to evaluate the efficacy of a seaweed mud application in improving both the structure and function of tissues affected by cellulite. Sixty women with cellulite underwent 4-week applications of seaweed mud on the buttocks and thighs. The following assessments were performed at baseline and after the last treatment: photographic, clinical, and anthropometric evaluation; tests for elasticity and hydration; ultrasonography of cellulite nodules; and cellulite biopsies in the trochanteric region. Patient satisfaction was assessed using a 5-point Likert-scale questionnaire. The treatment resulted in a significant improvement in the severity of cellulite severity between the initial assessment and the 4-week follow-up, with enhanced structure, elasticity, and hydration of the affected tissues. Microscopic analysis of the cellulite biopsies revealed a significant restoration of dermal organization with induced collagen synthesis and reduced inflammation, edema, and lipid deposition following the 4-week seaweed mud applications. Additionally, the treatment led to a remarkable improvement in comfort and satisfaction as well as a reduction in body circumferences. The cosmetic application of seaweed mud has proven to be a safe, non-invasive treatment for improving the tissue alterations characteristic of cellulite.

Sections du résumé

BACKGROUND BACKGROUND
Cellulite represents a common multi-factorial condition that affects nearly all women and is now recognized as a clinical condition associated with systemic factors and negative psychological effects. Several noninvasive and minimally invasive treatments were developed during the last few years, but limited evidence supports many of them due to lack of evidence, insufficient participants, and potential adverse effects.
METHODS METHODS
This study aimed to evaluate the efficacy of a seaweed mud application in improving both the structure and function of tissues affected by cellulite. Sixty women with cellulite underwent 4-week applications of seaweed mud on the buttocks and thighs. The following assessments were performed at baseline and after the last treatment: photographic, clinical, and anthropometric evaluation; tests for elasticity and hydration; ultrasonography of cellulite nodules; and cellulite biopsies in the trochanteric region. Patient satisfaction was assessed using a 5-point Likert-scale questionnaire.
RESULTS RESULTS
The treatment resulted in a significant improvement in the severity of cellulite severity between the initial assessment and the 4-week follow-up, with enhanced structure, elasticity, and hydration of the affected tissues. Microscopic analysis of the cellulite biopsies revealed a significant restoration of dermal organization with induced collagen synthesis and reduced inflammation, edema, and lipid deposition following the 4-week seaweed mud applications. Additionally, the treatment led to a remarkable improvement in comfort and satisfaction as well as a reduction in body circumferences.
CONCLUSIONS CONCLUSIONS
The cosmetic application of seaweed mud has proven to be a safe, non-invasive treatment for improving the tissue alterations characteristic of cellulite.

Identifiants

pubmed: 38450959
doi: 10.1111/jocd.16268
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024 The Authors. Journal of Cosmetic Dermatology published by Wiley Periodicals LLC.

Références

Friedmann DP, Vick GL, Mishra V. Cellulite: a review with a focus on subcision. Clin Cosmet Investig Dermatol. 2017;10:17-23. doi:10.2147/CCID.S95830
Arora G, Patil A, Hooshanginezhad Z, et al. Cellulite: presentation and management. J Cosmet Dermatol. 2022;21:1393-1401. doi:10.1111/JOCD.14815
Young VL, Dibernardo BE. Comparison of cellulite severity scales and imaging methods. Aesthet Surg J. 2021;41:NP521-NP537. doi:10.1093/ASJ/SJAA226
Tokarska K, Tokarski S, Woźniacka A, Sysa-Jędrzejowska A, Bogaczewicz J. Cellulite: a cosmetic or systemic issue? Contemporary views on the etiopathogenesis of cellulite. Adv Dermatology Allergol Dermatologii i Alergol. 2018;35:442-446. doi:10.5114/ADA.2018.77235
Scarano A, Amuso D, Amore M, et al. Carboxytherapy with oxygen propulsion treatment of cellulite is more effective in women not affected by periodontal disease. J Biol Regul Homeost Agents. 2020;34(6):2337-2342. doi:10.23812/20-369-L
Rosenbaum M, Prieto V, Hellmer J, et al. An exploratory investigation of the morphology and biochemistry of cellulite. Plast Reconstr Surg. 1998;101:1934-1939. doi:10.1097/00006534-199806000-00025
Steven S, Frenis K, Oelze M, et al. Vascular inflammation and oxidative stress: major triggers for cardiovascular disease. Oxid Med Cell Longev. 2019;2019:1-26. doi:10.1155/2019/7092151
Bass LS, Kaminer MS. Insights into the pathophysiology of cellulite: a review. Dermatol Surg. 2020;46:S77-S85. doi:10.1097/DSS.0000000000002388
Hexsel D, Soirefmann M. Cosmeceuticals for cellulite. Semin Cutan Med Surg. 2011;30:167-170. doi:10.1016/J.SDER.2011.06.005
Wassef C, Rao BK. The science of cellulite treatment and its long-term effectiveness. J Cosmet Laser Ther. 2012;14:50-58. doi:10.3109/14764172.2012.670706
Sadick N. Treatment for cellulite. Int J women's Dermatol. 2018;5:68-72. doi:10.1016/J.IJWD.2018.09.002
Thiyagarasaiyar K, Goh BH, Jeon YJ, Yow YY. Algae metabolites in cosmeceutical: an overview of current applications and challenges. Mar Drugs. 2020;18:323. doi:10.3390/MD18060323
Bedoux G, Hardouin K, Burlot AS, Bourgougnon N. Bioactive components from seaweeds: cosmetic applications and future development. Advances in Botanical Research, Vol.71. Academic Press; 2014:345-378. doi:10.1016/B978-0-12-408062-1.00012-3
Pereira L. Seaweeds as source of bioactive substances and skin care therapy-cosmeceuticals, algotheraphy, and thalassotherapy. Cosmetologica. 2018;68(5):68. doi:10.3390/COSMETICS5040068
Pimentel FB, Alves RC, Rodrigues F, Oliveira MBPP. Macroalgae-derived ingredients for cosmetic industry-an update. Cosmetologica. 2017;5(1):2. doi:10.3390/COSMETICS5010002
Jesumani V, Du H, Aslam M, et al. Potential use of seaweed bioactive compounds in skincare-a review. Mar Drugs. 2019;17:688. doi:10.3390/MD17120688
Sharma PP, Chonche MJ, Mudhol S, Muthukumar SP, Baskaran V. Anti-inflammatory efficacy of brown seaweed (Padina tetrastromatica) in 3T3-L1 adipocytes and low-dose LPS induced inflammation in C57BL6 mice. Algal Res. 2023;71:103027. doi:10.1016/J.ALGAL.2023.103027
Olsthoorn SEM, Wang X, Tillema B, et al. Brown seaweed food supplementation: effects on allergy and inflammation and its consequences. Nutrients. 2021;13:2613. doi:10.3390/nu13082613
Murphy MJ, Dow AA. Clinical studies of the safety and efficacy of macroalgae extracts in cosmeceuticals. J Clin Aesthet Dermatol. 2021;14:37-41.
Rossi AM, Katz BE. A modern approach to the treatment of cellulite. Dermatol Clin. 2014;32:51-59. doi:10.1016/J.DET.2013.09.005
Scarano A, Petrini M, Sbarbati A, et al. Pilot study of histology aspect of cellulite in seventy patients who differ in BMI and cellulite grading. J Cosmet Dermatol. 2021;20:4024-4031. doi:10.1111/jocd.14584
Cherry P, O'hara C, Magee PJ, et al. Risks and benefits of consuming edible seaweeds. Nutr Rev. 2019;77:307-329. doi:10.1093/NUTRIT/NUY066
Amaro HM, Pagels F, Tavares TG, et al. Antioxidant and anti-inflammatory potential of seaweed extracts as functional ingredients. Hydrobiologia. 2022;1:469-482. doi:10.3390/HYDROBIOLOGY1040028
Medoro A, Davinelli S, Milella L, et al. Dietary Astaxanthin: a promising antioxidant and anti-inflammatory agent for brain aging and adult neurogenesis. Mar Drugs. 2023;21(12):643. doi:10.3390/MD21120643
Medoro A, Intrieri M, Passarella D, Willcox DC, Davinelli S, Scapagnini G. Astaxanthin as a metabolic regulator of glucose and lipid homeostasis. J Funct Foods. 2024;112:105937. doi:10.1016/J.JFF.2023.105937
Al-Bader T, Byrne A, Gillbro J, et al. Effect of cosmetic ingredients as anticellulite agents: synergistic action of actives with in vitro and in vivo efficacy. J Cosmet Dermatol. 2012;11:17-26. doi:10.1111/J.1473-2165.2011.00594.X
Yokota T, Nagashima M, Ghazizadeh M, Kawanami O. Increased effect of fucoidan on lipoprotein lipase secretion in adipocytes. Life Sci. 2009;84:523-529. doi:10.1016/J.LFS.2009.01.020
Kim MJ, Chang UJ, Lee JS. Inhibitory effects of Fucoidan in 3T3-L1 adipocyte differentiation. Mar Biotechnol (NY). 2009;11:557-562. doi:10.1007/S10126-008-9170-1
Conti G, Zingaretti N, Amuso D, et al. Proteomic and ultrastructural analysis of cellulite-new findings on an old topic. Int J Mol Sci. 2020;21:2077. doi:10.3390/IJMS21062077
Siems W, Grune T, Voss P, Brenke R. Anti-fibrosclerotic effects of shock wave therapy in lipedema and cellulite. Biofactors. 2005;24:275-282. doi:10.1002/BIOF.5520240132
Reich K, Warren RB, Lebwohl M, et al. Bimekizumab versus secukinumab in plaque psoriasis. Biofactors. 2005;384:142-152. doi:10.1056/NEJMOA2102383
Bacci PA, Allegra C, Albergati F, et al. Randomized, placebo-controlled double-blind clinical study of the efficacy of a multifunctional plant complex in the treatment of so-called “cellulite”. Int J Cosmet Surg Aesthetic Dermatol. 2003;5:53-68. doi:10.1089/153082003767787196

Auteurs

Domenico Amuso (D)

Department of Innovative Technologies in Medicine and Dentistry, University of Chieti-Pescara, Chieti, Italy.

Alessandro Medoro (A)

Department of Medicine and Health Sciences "V. Tiberio", University of Molise, Campobasso, Italy.

Giovanni Scapagnini (G)

Department of Medicine and Health Sciences "V. Tiberio", University of Molise, Campobasso, Italy.

Angela Gambacorta (A)

USL Umbria 1, Perugia, Italy.

Sergio Davinelli (S)

Department of Medicine and Health Sciences "V. Tiberio", University of Molise, Campobasso, Italy.

Eugenio Luigi Iorio (EL)

Campus Uberlândia, Universidade de Uberaba (UNIUBE), Uberlândia, Brazil.

Luca Reggiani Bonetti (LR)

Department of Medical and Surgical Sciences for Children & Adults, Division of Pathology, University-Hospital of Modena and Reggio Emilia, Modena, Italy.

Andrea Sbarbati (A)

Department of Neurosciences, Biomedicine and Movement Sciences, Anatomy and Histology Section, School of Medicine, University of Verona, Verona, Italy.

Classifications MeSH